L
L&C Bio
Q2 2026 earnings
Quarter
Apr – Jun
Released
August 11, 2026(KST)
Revenue
This quarter₩38.8B
Analyst estimate₩38.3B▲ +1.4%
Year ago (Jun '25)₩20.6B▲ +88.4%
EPS
This quarter-₩1,038
Analyst estimate₩136
Verifying this figure against consensus
Revenue Growth Trajectory
+88%YoY
Last 6 quarters
Next quarter net income ₩12.9B est.
Analyst consensus · ₩45.3B · 3 analysts
As of 9/5, 08:31 KST
